Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Acco Brands Corporation, 3 years.
Acco Brands Corporation
Director
Prestige Consumer Healthcare Inc.
Director · Chief Executive Officer
Chief executive roles
Prestige Consumer Healthcare Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 7, 2026 | Prestige Consumer Healthcare Inc. | Shares withheld for tax | −2,543 | $54.59 | $138,822 |
| May 5, 2026 | Prestige Consumer Healthcare Inc. | Shares withheld for tax | −2,197 | $55.75 | $122,483 |
| May 4, 2026 | Prestige Consumer Healthcare Inc. | Grant or award | +31,468 | — | — |
| May 4, 2026 | Prestige Consumer Healthcare Inc. | Shares withheld for tax | −16,789 | $55.31 | $928,600 |
| May 4, 2026 | Prestige Consumer Healthcare Inc. | Grant or award | +19,662 | — | — |
| May 2, 2026 | Prestige Consumer Healthcare Inc. | Shares withheld for tax | −2,665 | $55.09 | $146,815 |
| May 7, 2025 | Prestige Consumer Healthcare Inc. | Shares withheld for tax | −2,305 | $81.41 | $187,650 |
| May 5, 2025 | Prestige Consumer Healthcare Inc. | Grant or award | +12,352 | — | — |
| May 5, 2025 | Prestige Consumer Healthcare Inc. | Grant or award | +39,904 | — | — |
| May 5, 2025 | Prestige Consumer Healthcare Inc. | Shares withheld for tax | −19,294 | $82.98 | $1,601,016 |
| May 2, 2025 | Prestige Consumer Healthcare Inc. | Shares withheld for tax | −2,664 | $84.19 | $224,282 |
| May 2, 2025 | Prestige Consumer Healthcare Inc. | Shares withheld for tax | −2,416 | $84.19 | $203,403 |
| Nov 19, 2024 | Prestige Consumer Healthcare Inc. | Option exercise | +5,213 | $57.18 | $298,079 |
| Nov 19, 2024 | Prestige Consumer Healthcare Inc. | Open-market sale | −5,213 | $82.55 | $430,333 |
| Nov 19, 2024 | Prestige Consumer Healthcare Inc. | Option exercise | +5,662 | $56.11 | $317,695 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.